Skip to main content

Advertisement

Log in

Development of Fluoride-Loaded Chitosan Microparticles for Controlled Drug Delivery: A Comparative Study of PVP K17 and Eudragit® RS 30D as Coating Polymer

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

The oral administration of drugs is usually the most convenient, economical, and preferred route for patients. Chitosan is a natural polymer that is biocompatible and possesses good mucoadhesion properties and has been proposed for various biomedical applications such as scaffolds in tissue engineering, wound dressing, and drug release systems. Fluoride is recognized for its ability to stimulate osteoblast differentiation and for its anticariogenic properties. When administered in low doses, it increases bone mass and reduces the risk of vertebral fractures in patients with osteoporosis. However, there is a debate about the potential negative effects of fluoride when applied in high doses or chronically. The objective of this study was to investigate the release of fluoride from chitosan microparticles loaded with fluoride and coated with two polymers, aimed at controlling its delivery.

Methods

Fluoride-loaded chitosan microparticles were developed using fluidized bed technology. Additionally, polyvinylpyrrolidone (PVP) and Eudragit® RS were applied to the particles using fluidized bed and dip-coating techniques. The obtained particles were then studied to obtain their release profiles. Infrared spectroscopy studies were conducted to analyze the chemical composition of the particles.

Results

The results showed that the coatings had a slight effect on the release of fluoride from the particles when applied using fluidized bed technology. Eudragit RS® 30D coatings by immersion were found to be more effective in sustaining release of fluoride.

Conclusion

The study provides useful insights into the use of polymeric coatings in the development of chitosan-based oral delivery systems for the controlled release of a highly soluble API.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

Data can be available on request.

References

  1. Chan KY, Ng KP, Sim DS, et al. Pharmacological basis of acute care. Cham: Springer International Publishing; 2015.

    Book  Google Scholar 

  2. Rabišková M, Bautzová T, Gajdziok J, et al. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. Int J Pharm. 2012;422:151–9. https://doi.org/10.1016/j.ijpharm.2011.10.045.

    Article  PubMed  CAS  Google Scholar 

  3. García MC, Martinelli M, Ponce NE, et al. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes. Elsevier B.V. 2018.

  4. Priese F, Frisch T, Wolf B, et al. Comparison of film-coated retarded release pellets manufactured by layering technique or by bed rotor pelletization. Pharm Dev Technol. 2015;20:417–25. https://doi.org/10.3109/10837450.2013.879883.

    Article  PubMed  CAS  Google Scholar 

  5. Rahmanian-Devin P, Baradaran Rahimi V, Askari VR, et al. Thermosensitive chitosan-β-glycerophosphate hydrogels as targeted drug delivery systems: an overview on preparation and their applications. Adv Pharmacol Pharm Sci. 2021;2021:1–17. https://doi.org/10.1155/2021/6640893.

    Article  CAS  Google Scholar 

  6. Pasaribu KM, Ilyas S, Tamrin T, et al. Bioactive bacterial cellulose wound dressings for burns with collagen in-situ and chitosan ex-situ impregnation. Int J Biol Macromol. 2023;230:123118. https://doi.org/10.1016/J.IJBIOMAC.2022.123118.

    Article  PubMed  CAS  Google Scholar 

  7. Seidi F, Khodadadi Yazdi M, Jouyandeh M, et al. Chitosan-based blends for biomedical applications. Int J Biol Macromol. 2021;183:1818–50. https://doi.org/10.1016/J.IJBIOMAC.2021.05.003.

    Article  PubMed  CAS  Google Scholar 

  8. Ullah R, Zafar MS. Oral and dental delivery of fluoride: a review. Fluoride. 2015;48:195–204.

    CAS  Google Scholar 

  9. National Research Council. Fluoride in drinking water. Washington, D.C.: National Academies Press; 2006.

    Google Scholar 

  10. Duffin S, Duffin M, Grootveld M, et al. Revisiting fluoride in the twenty-first century: safety and efficacy considerations. Front Oral Health. 2022;3:45. https://doi.org/10.3389/FROH.2022.873157.

    Article  Google Scholar 

  11. Rubin CD, Pak CY, Adams-Huet B, et al. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis. Arch Intern Med. 2001;161:2325–33. ioi01001 [pii].

  12. Rigalli A, Aguirre C, Armendáriz M, Cassiraga G, et al. Formulación de modelos matemáticos de fenómenos biológicos, 1a. Argentina: UNR EDITORA - Universidad Nacional de Rosario, Rosario; 2003.

    Google Scholar 

  13. Buzalaf MAR, Leite AL, Carvalho NTA, et al. Bioavailability of fluoride administered as sodium fluoride or monofluorophosphate to humans. J Fluor Chem. 2008;129:691–4. https://doi.org/10.1016/j.jfluchem.2008.06.005.

    Article  CAS  Google Scholar 

  14. Sharma D, Singh A, Verma K, et al. Fluoride: a review of pre-clinical and clinical studies. Environ Toxicol Pharmacol. 2017;56:297–313. https://doi.org/10.1016/j.etap.2017.10.008.

    Article  PubMed  CAS  Google Scholar 

  15. Menoyo I, Rigalli A, Puche RC, et al. Effect of fluoride on the secretion of insulin in the rat. Arzneimittel-Forschung/Drug Research. 2005;55:455–60.

    PubMed  CAS  Google Scholar 

  16. Nguyen S, Escudero C, Sediqi N, et al. Fluoride loaded polymeric nanoparticles for dental delivery. Eur J Pharm Sci. 2017;104:326–34. https://doi.org/10.1016/j.ejps.2017.04.004.

    Article  PubMed  CAS  Google Scholar 

  17. Keegan GM, Smart JD, Ingram MJ, et al. Chitosan microparticles for the controlled delivery of fluoride. J Dent. 2012;40:229–40. https://doi.org/10.1016/j.jdent.2011.12.012.

    Article  PubMed  CAS  Google Scholar 

  18. Fookes FA, Mengatto LN, Rigalli A, Luna JA, et al. Controlled fluoride release for osteoporosis treatment using orally administered chitosan hydrogels. J Drug Deliv Sci Technol. 2019;51:268–75. https://doi.org/10.1016/j.jddst.2019.03.004.

    Article  CAS  Google Scholar 

  19. Kaur K, Kim K. Studies of chitosan/organic acid/Eudragit® RS/RL-coated system for colonic delivery. Int J Pharm. 2009;366:140–8. https://doi.org/10.1016/j.ijpharm.2008.09.006.

    Article  PubMed  CAS  Google Scholar 

  20. Fookes F, Busatto C, Eugenia Taverna M, et al. Morphology modulation of silica mesoporous nano- and microparticles for atrazine - controlled release. Environ Nanotechnol Monit Manag. 2022;18:100712. https://doi.org/10.1016/j.enmm.2022.100712.

    Article  CAS  Google Scholar 

  21. Karp F, Turino LN, Estenoz D, et al. Encapsulation of florfenicol by in situ crystallization into novel alginate-Eudragit RS®blended matrix for pH modulated release. J Drug Deliv Sci Technol. 2019;54:101241. https://doi.org/10.1016/j.jddst.2019.101241.

  22. Simionato LD, Petrone L, Baldut M, et al. Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina. Saudi Pharmaceutical Journal. 2018;26:578–84. https://doi.org/10.1016/j.jsps.2018.01.015.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35. https://doi.org/10.1016/0378-5173(83)90064-9.

    Article  CAS  Google Scholar 

  24. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–33. https://doi.org/10.1016/S0928-0987(01)00095-1.

    Article  PubMed  CAS  Google Scholar 

  25. Harris RE. Quitosanto, un biopolímero con aplicaciones en sistemas de liberación controlada de Fármacos. Universidad Complutense de Madrid. 2010.

  26. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2020;1:2673.

    Google Scholar 

  27. Hu H, Yang L, Lin Z, et al. A low-cost and environment friendly chitosan/aluminum hydroxide bead adsorbent for fluoride removal from aqueous solutions. Iran Polym J. 2018;27:253–61. https://doi.org/10.1007/s13726-018-0605-x.

    Article  CAS  Google Scholar 

  28. Zhu T, Zhu T, Gao J, et al. Enhanced adsorption of fluoride by cerium immobilized cross-linked chitosan composite. J Fluor Chem. 2017;194:80–8. https://doi.org/10.1016/j.jfluchem.2017.01.002.

    Article  CAS  Google Scholar 

  29. Alotaibi HF, Elsamaligy S, Mahrous GM, et al. Design of taste masked enteric orodispersible tablets of diclofenac sodium by applying fluid bed coating technology. Saudi Pharmaceutical Journal. 2019;27:354–62. https://doi.org/10.1016/j.jsps.2018.12.003.

    Article  PubMed  Google Scholar 

  30. Fernández Cervera M, Heinämäki J, Räsänen E, et al. Determination of tackiness of chitosan film-coated pellets exploiting minimum fluidization velocity. Int J Pharm. 2004;281:119–27. https://doi.org/10.1016/j.ijpharm.2004.06.004.

    Article  PubMed  CAS  Google Scholar 

  31. Yang Z, Craig DQM. Monitoring film coalescence from aqueous polymeric dispersions using atomic force microscopy: surface topographic and nano-adhesion studies. Asian J Pharm Sci. 2020;15:104–11. https://doi.org/10.1016/j.ajps.2018.09.008.

    Article  PubMed  Google Scholar 

  32. Hudovornik G, Vrečer F. Impact of the curing parameters on drug release from Eudragit RS and RL 30D coated pellets: design of experiments. J Drug Deliv Sci Technol. 2015;30:146–53. https://doi.org/10.1016/j.jddst.2015.09.021.

    Article  CAS  Google Scholar 

  33. Fernandez Aragon J, González Santos R, Estévez Fuentes G, et al. Cinética de liberación de cefalexiana desde un biomaterial compuesto. An R Acad Nac Farm. 2009;75:345–63.

    Google Scholar 

  34. Patra ChN, Priya R, Swain S, et al. Pharmaceutical significance of Eudragit: a review. Futur J Pharm Sci. 2017;3:33–45. https://doi.org/10.1016/j.fjps.2017.02.001.

    Article  Google Scholar 

  35. Piao H, Liu S, Piao H, et al. Development of an osmotically-driven pellet coated with acrylic copolymers (Eudragit® RS 30 D) for the sustained release of oxymatrine, a freely water soluble drug used to treat stress ulcers (I): in vitro and in vivo evaluation in rabbits. Drug Dev Ind Pharm. 2013;39:1230–7. https://doi.org/10.3109/03639045.2012.707206.

    Article  PubMed  CAS  Google Scholar 

  36. Kibria G, Roni MA, Absar MS, Jalil R, et al. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS PharmSciTech. 2008;9:1240–6. https://doi.org/10.1208/s12249-008-9163-4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Kibria G, Islam KMA, Jalil R-U, et al. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer. Pak J Pharm Sci. 2009;22:36–43.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to express their gratitude to the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) and the Universidad Nacional del Litoral (UNL) of Argentina for the financial support provided for this contribution. We would also like to express our gratitude to the late Dr. Ignacio Helbling for his invaluable contributions to this research.

Author information

Authors and Affiliations

Authors

Contributions

Material preparation, data collection and analysis, and writing, original draft preparation, were performed by Federico A. Fookes. Review, editing, and analysis were performed by Natalia S. Velázquez. Supervision, review, and editing were performed by Alfredo Rigalli. Supervision, review, and editing were performed by Julio A. Luna.

Corresponding author

Correspondence to Federico A. Fookes.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fookes, F.A., Velázquez, N.S., Rigalli, A. et al. Development of Fluoride-Loaded Chitosan Microparticles for Controlled Drug Delivery: A Comparative Study of PVP K17 and Eudragit® RS 30D as Coating Polymer. J Pharm Innov 18, 1941–1953 (2023). https://doi.org/10.1007/s12247-023-09765-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-023-09765-y

Keywords

Navigation